Cargando…
Safety and tolerability of tedizolid as oral treatment for bone and joint infections
Bone and joint infections (BJIs) are common infections increasingly managed with oral therapy. However, there are limited safe oral options for many Gram-positive pathogens. In animal studies and short-term human use, tedizolid lacks the hematologic and neurologic toxicity of the other available oxa...
Autores principales: | Miller, Loren G., Flores, Evelyn A., Launer, Bryn, Lee, Pamela, Kalkat, Praneet, Derrah, Kelli, Agrawal, Shalini, Schwartz, Matthew, Steele, Grant, Kim, Tae, Kuvhenguhwa, Maita S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581034/ https://www.ncbi.nlm.nih.gov/pubmed/37750695 http://dx.doi.org/10.1128/spectrum.01282-23 |
Ejemplares similares
-
306. Safety and Tolerability of Tedizolid as Oral Treatment for Bone and Joint Infections
por: Launer, Bryn, et al.
Publicado: (2018) -
A Case of Early Prosthetic Valve Endocarditis Caused by Staphylococcus warneri in a Patient Presenting With Congestive Heart Failure
por: Kuvhenguhwa, Maita S., et al.
Publicado: (2017) -
Tolerance of Prolonged Oral Tedizolid for Prosthetic Joint Infections: Results of a Multicentre Prospective Study
por: Senneville, Eric, et al.
Publicado: (2020) -
Pharmacokinetics and Pharmacodynamics of Tedizolid
por: Iqbal, Khalid, et al.
Publicado: (2022) -
2287. Real-world Use of Tedizolid Phosphate: A Case Series of Long-Term Tolerability
por: Morrisette, Taylor, et al.
Publicado: (2019)